{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:07:04Z","timestamp":1788502024328,"version":"build-2803163510"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Class I Human Leukocyte Antigen (HLA) evolutionary divergence (HED) is a metric which reflects immunopeptidome diversity and has been associated with immune checkpoint inhibitor responses in solid tumors. Its impact and interest in allogeneic hematopoietic stem cell transplantation (HCT) have not yet been thoroughly studied. This study analyzed the clinical and immune impact of class I and II HED in 492 acute myeloid leukemia (AML) recipients undergoing HCT. The overall cohort was divided into a training (n=338) and a testing (n=132) set. Univariate cox screening found a positive impact of a high class I HED and a negative impact of a high class II HED on both disease-free (DFS) and overall survival (OS). These results were combined in a unique marker, class I\/class II HED ratio, and assessed in the testing cohort. The final multivariate cox model confirmed the positive impact of a high\n                    <jats:italic>versus<\/jats:italic>\n                    low class I\/class II HED ratio on both DFS (Hazard Ratio (HR) 0.41 [95% CI 0.2-0.83]; p=0.01) and OS (HR 0.34 [0.19-0.59]; p&amp;lt;0.001), independently of HLA matching and other HCT parameters. No significant association was found between the ratio and graft-versus-host disease (GvHD) nor with neutrophil and platelet recovery. A high class I HED was associated with a tendency for an increase in NK, CD8 T-cell, and B cell recovery at 12 months. These results introduce HED as an original and independent prognosis marker reflecting immunopeptidome diversity and alloreactivity after HCT.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2022.841470","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T02:54:04Z","timestamp":1646362444000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Class I\/Class II HLA Evolutionary Divergence Ratio Is an Independent Marker Associated With Disease-Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia"],"prefix":"10.3389","volume":"13","author":[{"given":"Anne-Marie","family":"Daull","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Labussi\u00e8re-Wallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Venet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorenza","family":"Barraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Ducastelle-Lepretre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Virginie","family":"Larcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Balsat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lila","family":"Gilis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Fossard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Ghesqui\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00ebl","family":"Heiblig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Ader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Alcazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00496","article-title":"Graft-Versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia","volume":"8","author":"Dickinson","year":"2017","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/bjh.13959","article-title":"Advances in Understanding the Pathogenesis of Graft-Versus-Host Disease","volume":"173","author":"Magenau","year":"2016","journal-title":"Br J Haematol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.141119","article-title":"How to Select the Best Available Related or Unrelated Donor of Hematopoietic Stem Cells","volume":"101","author":"Tiercy","year":"2016","journal-title":"Haematologica"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-030858","article-title":"Beyond HLA: The Significance of Genomic Variation for Allogeneic Hematopoietic Stem Cell Transplantation","volume":"109","author":"Mullally","year":"2006","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-737700","article-title":"Genome-Wide Minor Histocompatibility Matching as Related to the Risk of Graft-Versus-Host Disease","volume":"129","author":"Martin","year":"2017","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/science.1195271","article-title":"The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation","volume":"330","author":"Pereyra","year":"2010","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1126\/science.272.5258.67","article-title":"Population Biology of Antigen Presentation by MHC Class I Molecules","volume":"272","author":"Parham","year":"1996","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao4572","article-title":"Patient HLA Class I Genotype Influences Cancer Response to Checkpoint Blockade Immunotherapy","volume":"359","author":"Chowell","year":"2018","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0639-4","article-title":"Evolutionary Divergence of HLA Class I Genotype Impacts Efficacy of Cancer Immunotherapy","volume":"25","author":"Chowell","year":"2019","journal-title":"Nat Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.7326\/M20-7957","article-title":"Donor HLA Class 1 Evolutionary Divergence Is a Major Predictor of Liver Allograft Rejection\u00a0: A Retrospective Cohort Study","volume":"174","author":"F\u00e9ray","year":"2021","journal-title":"Ann Intern Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and Management of AML in Adults: 2017 ELN Recommendations From an International Expert Panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.185.4154.862","article-title":"Amino Acid Difference Formula to Help Explain Protein Evolution","volume":"185","author":"Grantham","year":"1974","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msy116","article-title":"Divergent Allele Advantage at Human MHC Genes: Signatures of Past and Ongoing Selection","volume":"35","author":"Pierini","year":"2018","journal-title":"Mol Biol Evol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1161","article-title":"The IPD and IMGT\/HLA Database: Allele Variant Databases","volume":"43","author":"Robinson","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1098","article-title":"Ensembl 2018","volume":"46","author":"Zerbino","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.21105\/joss.02630","article-title":"StatAid: An R Package With a Graphical User Interface for Data Analysis","volume":"5","author":"Alcazer","year":"","journal-title":"JOSS"},{"key":"B17","unstructured":"TherneauTM\n          Survival Analysis [R Package Survival Version 3.2-11]2021"},{"key":"B18","volume-title":"R: A Language and Environment for Statistical Computing","year":"2020"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-097386","article-title":"High-Resolution Donor-Recipient HLA Matching Contributes to the Success of Unrelated Donor Marrow Transplantation","volume":"110","author":"Lee","year":"2007","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1159\/000502263","article-title":"HLA Matching in Unrelated Stem Cell Transplantation Up to Date","volume":"46","author":"F\u00fcrst","year":"2019","journal-title":"Transfus Med Hemother"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V75.3.555.bloodjournal753555","article-title":"Graft-Versus-Leukemia Reactions After Bone Marrow Transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-007427","article-title":"Host MHC Class II+ Antigen-Presenting Cells and CD4 Cells are Required for CD8-Mediated Graft-Versus-Leukemia Responses Following Delayed Donor Leukocyte Infusions","volume":"108","author":"Chakraverty","year":"2006","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.96","article-title":"Evidence for Anti-Tumour Effect of Allogeneic Haematopoietic SCT in Cases Without Sustained Donor Engraftment","volume":"45","author":"Daguindau","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.11.001","article-title":"Strategies for the Identification of T Cell\u2013Recognized Tumor Antigens in Hematological Malignancies for Improved Graft-Versus-Tumor Responses After Allogeneic Blood and Marrow Transplantation","volume":"21","author":"Zilberberg","year":"2015","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/0169-5347(90)90207-T","article-title":"Evolution of Diversity at the Major Histocompatibility Complex","volume":"5","author":"Potts","year":"1990","journal-title":"Trends Ecol Evol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1558-5646.2011.01288.x","article-title":"Computational Prediction of MHC II-Antigen Binding Supports Divergent Allele Advantage and Explains Trans-Species Polymorphism","volume":"65","author":"Lenz","year":"2011","journal-title":"Evol Int J Org Evol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071835","article-title":"HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation","volume":"12","author":"Roerden","year":"2020","journal-title":"Cancers"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/genetics\/133.3.669","article-title":"Contrasting Roles of Interallelic Recombination at the Hla-A and Hla-B Loci","volume":"133","author":"Hughes","year":"1993","journal-title":"Genetics"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006862","article-title":"Distinguishing Functional Polymorphism From Random Variation in the Sequences of >10,000 HLA-A, -B and -C Alleles","volume":"13","author":"Robinson","year":"2017","journal-title":"PloS Genet"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-016-0918-x","article-title":"HLA Class I Molecular Variation and Peptide-Binding Properties Suggest a Model of Joint Divergent Asymmetric Selection","volume":"68","author":"Buhler","year":"2016","journal-title":"Immunogenetics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/PL00006264","article-title":"The Evolution of MHC Diversity by Segmental Duplication and Transposition of Retroelements","volume":"45","author":"Kulski","year":"1997","journal-title":"J Mol Evol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.24.12000","article-title":"HLA-C is the Inhibitory Ligand That Determines Dominant Resistance to Lysis by NK1- and NK2-Specific Natural Killer Cells","volume":"90","author":"Colonna","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.6.2085","article-title":"Low HLA-C Expression at Cell Surfaces Correlates With Increased Turnover of Heavy Chain mRNA","volume":"181","author":"McCutcheon","year":"1995","journal-title":"J Exp Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nri1570","article-title":"MHC Class I Molecules and Kirs in Human History, Health and Survival","volume":"5","author":"Parham","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/tan.13396","article-title":"Molecular Evolution of Elements Controlling HLA-C Expression: Adaptation to a Role as a KIR Ligand Regulating NK Cell Function","volume":"92","author":"Anderson","year":"2018","journal-title":"HLA"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.blre.2012.10.001","article-title":"Genetics of Graft-Versus-Host Disease: The Major Histocompatibility Complex","volume":"27","author":"Petersdorf","year":"2013","journal-title":"Blood Rev"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02655.x","article-title":"The Biological Significance of HLA-DP Gene Variation in Haematopoietic Cell Transplantation","volume":"112","author":"Petersdorf","year":"2001","journal-title":"Br J Haematol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0827-3","article-title":"HLA-DPB1 Mismatch Reduce Relapse and Improve Survival in T-Cell Replete Unrelated Donor Allogeneic Stem Cell Transplantation","volume":"55","author":"Gr\u00f8nvold","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.614976","article-title":"The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis","volume":"11","author":"Mytilineos","year":"2021","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.841470\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T02:54:09Z","timestamp":1646362449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.841470\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2022.841470"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.841470","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"article-number":"841470"}}